1. JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms
   Andrea Arena et al, 2023, Experimental Hematology CrossRef
2. Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development
   Karolina Łuczkowska et al, 2022, International Journal of Molecular Sciences CrossRef
3. Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis
   Taro Akiyama et al, 2023, Human Cell CrossRef
4. Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
   Anneke D. van Dijk et al, 2024, Cancers CrossRef
5. β‑catenin inhibitors ICG‑001 and pyrvinium sensitize bortezomib‑resistant multiple myeloma cells to bortezomib
   Cuicui Wu, 2022, Oncology Letters CrossRef